Aker BioMarine Second Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.005 profit in 2Q 2023)

Aker BioMarine (OB:AKBM) Second Quarter 2024 Results

Key Financial Results

• Revenue: US$49.2m (up 4.2% from 2Q 2023).
• Net loss: US$2.90m (down from US$400.0k profit in 2Q 2023).
• US$0.03 loss per share (down from US$0.005 profit in 2Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Aker BioMarine Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Food industry in Norway.

Performance of the Norwegian Food industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Aker BioMarine's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com